{{Rsnum
|rsid=2334499
|Chromosome=11
|position=1675619
|Orientation=plus
|GMAF=0.4532
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 28.6 | 51.8 | 19.6
| HCB | 4.4 | 29.2 | 66.4
| JPT | 2.7 | 31.9 | 65.5
| YRI | 90.5 | 9.5 | 0.0
| ASW | 82.5 | 17.5 | 0.0
| CHB | 4.4 | 29.2 | 66.4
| CHD | 3.7 | 27.5 | 68.8
| GIH | 62.4 | 29.7 | 7.9
| LWK | 82.7 | 17.3 | 0.0
| MEX | 31.0 | 46.6 | 22.4
| MKK | 77.6 | 21.2 | 1.3
| TSI | 33.3 | 53.9 | 12.7
| HapMapRevision=28
}}

[[rs2334499]] is in a region of chromosome 11p15 which contains a cluster of imprinted genes.

This SNP, [[rs2334499]], has recently been reported to have an association with [[type-2 diabetes]]. The allele that confers risk when paternally inherited is protective when maternally inherited.{{PMID|20016592|OA=1
}}

{{omim
|id=125853
|rsnum=2334499
}}

{{PMID Auto
|PMID=21278902
|Title=Genetic risk profiling for prediction of type 2 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=23462794
|Title=Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
|OA=1
}}

{{PMID Auto
|PMID=23630301
|Title=Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}